+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Collagen Vascular Diseases Market by Product (Diagnosis, Treatments), Indication (Ankylosing Spondylitis, Dermatomyositis, Polyarteritis Nodosa), End-Use - Forecast 2024-2030- Product Image
Global Collagen Vascular Diseases Market by Product (Diagnosis, Treatments), Indication (Ankylosing Spondylitis, Dermatomyositis, Polyarteritis Nodosa), End-Use - Forecast 2024-2030- Product Image
Sale

Global Collagen Vascular Diseases Market by Product (Diagnosis, Treatments), Indication (Ankylosing Spondylitis, Dermatomyositis, Polyarteritis Nodosa), End-Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5924836
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Collagen Vascular Diseases Market size was estimated at USD 29.83 billion in 2023, USD 32.21 billion in 2024, and is expected to grow at a CAGR of 8.70% to reach USD 53.51 billion by 2030.

Collagen vascular diseases comprise a group of disorders that involve the protein-rich tissue that supports organs and other parts of the body. This connective tissue is essential for the strength, elasticity, and structure of skin, tendons, bones, cartilage, and blood vessels. Collagen vascular diseases can be hereditary or caused by an overactive immune system, resulting in autoimmune conditions where the body attacks its own tissues. These diseases often share common features, including inflammation, which can damage and dysfunction of affected organs and tissues.

The category encompasses a variety of conditions, including rheumatoid arthritis, scleroderma, systemic lupus erythematosus, polymyositis, dermatomyositis, and systemic sclerosis, among others. The market for collagen vascular diseases encompasses the demand and supply of medical solutions, including diagnostics, treatments, therapeutics, and services targeted towards diseases that affect connective tissue. Applications for this market include clinical diagnostics, therapeutic treatments, and ongoing patient management. End-users are typically healthcare facilities like hospitals, clinics, specialized rheumatology centers, and home care settings. This market also serves research and academic institutions and pharmaceutical and biotechnology companies involved in the development of new treatments. The key factors influencing the need for the collagen vascular diseases market include growing awareness and understanding of collagen vascular diseases, rising incidence of autoimmune diseases globally, improved healthcare infrastructure, and increased accessibility to medical services. However, the market faces challenges, such as high costs associated with advanced treatments and medications and stringent government regulations and approval processes. On the other hand, the need for collagen vascular diseases presents several burgeoning opportunities, such as ongoing advancements in gene and stem cell therapies and the adoption of telemedicine, mobile health applications, and wearables for patient management.

Regional Insights

The United States represents a significant market for collagen vascular diseases (CVDs), driven by a well-established healthcare infrastructure, patient awareness, and a high incidence of autoimmune diseases. The presence of leading pharmaceutical companies focusing on innovation, coupled with supportive government policies, contributes to market expansion. In South America, the collagen vascular diseases market is expanding as healthcare access improves and the population becomes more aware of these diseases. Government initiatives to strengthen healthcare provision and international collaborations for medical research are expected to propel the market further.

The EU's need for collagen vascular diseases is characterized by the availability of universal healthcare systems and a strong focus on research and development. Stringent regulations regarding drug approvals ensure a high standard of care. Consumers in this region expect state-of-the-art treatment facilities and are driven by the effectiveness and safety profiles of treatments. The Middle East is experiencing a rise in autoimmune disorders, including collagen vascular diseases, and due to a developing healthcare sector, there is a reliance on international guidelines and medications. Africa's capacity to manage collagen vascular diseases is varied, with a greater prevalence of these conditions and a scarcity of advanced treatments in many regions. China's market is rapidly expanding with a shift towards modern healthcare systems, and increased investment in healthcare by the government and private sector, paired with greater access to global pharmaceuticals, is influencing customer needs. Japan's market reflects a high degree of technological integration in healthcare, with a consumer base inclined towards innovation and treatment quality.

Market Trends by Segment

  • Product: Increasing usage of biopsy kits in collagen vascular diseases
  • Indication: Increasing utilization for indicating dermatomyositis
  • End-Use: Expanding usage among diagnostic centers & laboratories to diagnose various health conditions

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Quest Diagnostics and Scipher Medicine Collaborate to Scale Precision Medicine Access for Patients with Rheumatoid Arthritis

Quest Diagnostics and Scipher Medicine have forged a multi-year partnership to widen the scope of diagnostic capabilities for rheumatoid arthritis (RA) management, leveraging the pioneering PrismRA test. This molecular signature response classifier (MSRC) facilitates the prediction of responses to TNF inhibitor therapies, which is crucial for managing RA. Quest's service extension to include advanced RNA extraction and next-generation sequencing ensures a more efficient assessment of patient responses to TNF inhibitors. The partnership capitalizes on Quest’s nationwide network for specimen collection and sophisticated logistics, thereby enhancing patient access to precision diagnostic solutions.

FDA Approves First Tocilizumab Biosimilar For Treatment Of Rheumatoid Arthritis, JIA

Biogen has announced the FDA approval of Tofidence, the inaugural tocilizumab biosimilar authorized for use in the U.S., offering new treatment options for individuals with rheumatoid arthritis (RA) and certain juvenile arthritis conditions. This milestone promises increased healthcare savings and broader therapeutic access, according to the details provided by the manufacturer. Tofidence has been validated based on rigorous data analysis, including a phase 1 and phase 3 study, affirming its safety and efficacy as a biosimilar alternative to the reference drug Actemra.

American College of Rheumatology Launches New Toolkit Aimed at Measuring Rheumatoid Arthritis Outcomes

The American College of Rheumatology (ACR) has introduced its innovative Rheumatoid Arthritis (RA) Measures Toolkit, a comprehensive resource designed to dramatically enhance the quality of RA patient care. Emphasizing the importance of regular monitoring and individualized therapy, the toolkit offers invaluable tools, including training guides, multilingual outcome measure copies, and workflow samples, to ensure precise and effective tracking of disease activity and patient functionality.

Key Company Profiles

The report delves into recent significant developments in the Collagen Vascular Diseases Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Apollo Health and Lifestyle Limited, Augurex Life Sciences Corporation, Bayer AG, Beckman Coulter, Inc., Bio-Rad Laboratories Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb, Eli Lilly and Company, Exagen Inc., F. Hoffmann-La Roche Ltd, Getinge AB, Gilead Sciences, Inc., Illumina, Inc., Laboratory Corporation of America Holdings, LeMaitre Vascular, Inc., Merck KGaA, Novartis AG, PerkinElmer, Inc., Pfizer Inc,, QIAGEN GmbH, Siemens AG, Thermo Fisher Scientific, Inc., and Trinity Biotech PLC.

This research report offers invaluable insights into various crucial aspects of the Collagen Vascular Diseases Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing awareness and understanding of collagen vascular diseases
5.1.1.2. Rising incidence of autoimmune diseases globally
5.1.1.3. Improved healthcare infrastructure and increased accessibility to medical services
5.1.2. Restraints
5.1.2.1. High cost associated with advanced treatments and medications
5.1.3. Opportunities
5.1.3.1. Ongoing advancements in gene and stem cell therapies
5.1.3.2. Adoption of telemedicine, mobile health applications, and wearables for patient management
5.1.4. Challenges
5.1.4.1. Stringent government regulations and approval processes
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing usage of biopsy kits in collagen vascular diseases
5.2.2. Indication: Increasing utilization for indicating dermatomyositis
5.2.3. End-Use: Expanding usage among diagnostic centers & laboratories to diagnose various health conditions
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Collagen Vascular Diseases Market, by Product
6.1. Introduction
6.2. Diagnosis
6.3. Treatments
7. Collagen Vascular Diseases Market, by Indication
7.1. Introduction
7.2. Ankylosing Spondylitis
7.3. Dermatomyositis
7.4. Polyarteritis Nodosa
7.5. Polymyositis
7.6. Psoriatic Arthritis
7.7. Relapsing Polychondritis
7.8. Rheumatoid Arthritis
7.9. Scleroderma
7.10. Systemic Lupus Erythematosus
7.11. Vasculitis
8. Collagen Vascular Diseases Market, by End-Use
8.1. Introduction
8.2. Diagnostic Centers & Laboratories
8.3. Hospitals & Clinics
9. Americas Collagen Vascular Diseases Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Collagen Vascular Diseases Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Collagen Vascular Diseases Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Quest Diagnostics and Scipher Medicine Collaborate to Scale Precision Medicine Access for Patients with Rheumatoid Arthritis
12.3.2. FDA Approves First Tocilizumab Biosimilar For Treatment Of Rheumatoid Arthritis, JIA
12.3.3. American College of Rheumatology Launches New Toolkit Aimed at Measuring Rheumatoid Arthritis Outcomes
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. COLLAGEN VASCULAR DISEASES MARKET RESEARCH PROCESS
FIGURE 2. COLLAGEN VASCULAR DISEASES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. COLLAGEN VASCULAR DISEASES MARKET DYNAMICS
FIGURE 7. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. COLLAGEN VASCULAR DISEASES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. COLLAGEN VASCULAR DISEASES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. COLLAGEN VASCULAR DISEASES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOPSY, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOPSY, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BLOOD TEST, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BLOOD TEST, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ECHOCARDIOGRAM, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ECHOCARDIOGRAM, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY IMAGING TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY URINALYSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY URINALYSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDICATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ANKYLOSING SPONDYLITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ANKYLOSING SPONDYLITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DERMATOMYOSITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DERMATOMYOSITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY POLYARTERITIS NODOSA, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY POLYARTERITIS NODOSA, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY POLYMYOSITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY POLYMYOSITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PSORIATIC ARTHRITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PSORIATIC ARTHRITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY RELAPSING POLYCHONDRITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY RELAPSING POLYCHONDRITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SCLERODERMA, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SCLERODERMA, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SYSTEMIC LUPUS ERYTHEMATOSUS, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SYSTEMIC LUPUS ERYTHEMATOSUS, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSTIC CENTERS & LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSTIC CENTERS & LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 73. ARGENTINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 74. ARGENTINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 77. ARGENTINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 78. ARGENTINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 79. ARGENTINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 80. ARGENTINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 81. BRAZIL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 82. BRAZIL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 83. BRAZIL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 84. BRAZIL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 87. BRAZIL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 88. BRAZIL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 89. BRAZIL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 90. BRAZIL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 91. CANADA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 92. CANADA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 93. CANADA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 94. CANADA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 95. CANADA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 96. CANADA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 97. CANADA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 98. CANADA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 99. CANADA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 100. CANADA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 101. MEXICO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 102. MEXICO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 103. MEXICO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 104. MEXICO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 105. MEXICO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 106. MEXICO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 107. MEXICO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 108. MEXICO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 109. MEXICO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 110. MEXICO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 111. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 112. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 113. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 114. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 115. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 116. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 117. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 118. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 119. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 120. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 121. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 122. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 124. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 126. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 128. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 130. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 132. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 134. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 135. AUSTRALIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 136. AUSTRALIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 137. AUSTRALIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 138. AUSTRALIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 139. AUSTRALIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 140. AUSTRALIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 141. AUSTRALIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 142. AUSTRALIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 143. AUSTRALIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 144. AUSTRALIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 145. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 146. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 147. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 148. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 149. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 150. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 151. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 152. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 153. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 154. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 155. INDIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 156. INDIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 157. INDIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 158. INDIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 159. INDIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 160. INDIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 161. INDIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 162. INDIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 163. INDIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 164. INDIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 165. INDONESIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 166. INDONESIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 167. INDONESIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 168. INDONESIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 169. INDONESIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 170. INDONESIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 171. INDONESIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 172. INDONESIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 173. INDONESIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 174. INDONESIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 175. JAPAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 176. JAPAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 177. JAPAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 178. JAPAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 179. JAPAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 180. JAPAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 181. JAPAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 182. JAPAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 183. JAPAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 184. JAPAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 185. MALAYSIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 186. MALAYSIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 187. MALAYSIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 188. MALAYSIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 189. MALAYSIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 190. MALAYSIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 191. MALAYSIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 192. MALAYSIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 193. MALAYSIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 194. MALAYSIA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 195. PHILIPPINES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 196. PHILIPPINES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 197. PHILIPPINES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 198. PHILIPPINES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 199. PHILIPPINES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 200. PHILIPPINES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 201. PHILIPPINES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 202. PHILIPPINES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 203. PHILIPPINES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 204. PHILIPPINES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 205. SINGAPORE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 206. SINGAPORE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 207. SINGAPORE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 208. SINGAPORE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 209. SINGAPORE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 210. SINGAPORE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 211. SINGAPORE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 212. SINGAPORE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 213. SINGAPORE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 214. SINGAPORE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 215. SOUTH KOREA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 216. SOUTH KOREA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 217. SOUTH KOREA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 218. SOUTH KOREA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 219. SOUTH KOREA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 220. SOUTH KOREA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 221. SOUTH KOREA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 222. SOUTH KOREA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 223. SOUTH KOREA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 224. SOUTH KOREA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 225. TAIWAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 226. TAIWAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 227. TAIWAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 228. TAIWAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 229. TAIWAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 230. TAIWAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 231. TAIWAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 232. TAIWAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 233. TAIWAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 234. TAIWAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 235. THAILAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 236. THAILAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 237. THAILAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 238. THAILAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 239. THAILAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 240. THAILAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 241. THAILAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 242. THAILAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 243. THAILAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 244. THAILAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 245. VIETNAM COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 246. VIETNAM COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 247. VIETNAM COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 248. VIETNAM COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 249. VIETNAM COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 250. VIETNAM COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 251. VIETNAM COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 252. VIETNAM COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 253. VIETNAM COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 254. VIETNAM COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 267. DENMARK COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 268. DENMARK COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 269. DENMARK COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 270. DENMARK COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 271. DENMARK COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 272. DENMARK COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 273. DENMARK COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 274. DENMARK COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 275. DENMARK COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 276. DENMARK COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 277. EGYPT COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 278. EGYPT COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 279. EGYPT COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 280. EGYPT COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 281. EGYPT COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 282. EGYPT COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 283. EGYPT COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 284. EGYPT COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 285. EGYPT COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 286. EGYPT COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 287. FINLAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 288. FINLAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 289. FINLAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 290. FINLAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 291. FINLAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 292. FINLAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 293. FINLAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 294. FINLAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 295. FINLAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 296. FINLAND COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 297. FRANCE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 298. FRANCE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 299. FRANCE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 300. FRANCE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 301. FRANCE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 302. FRANCE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 303. FRANCE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 304. FRANCE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 305. FRANCE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 306. FRANCE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 307. GERMANY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 308. GERMANY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 309. GERMANY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 310. GERMANY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 311. GERMANY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 312. GERMANY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 313. GERMANY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 314. GERMANY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 315. GERMANY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 316. GERMANY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 317. ISRAEL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 318. ISRAEL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 319. ISRAEL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 320. ISRAEL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 321. ISRAEL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2018-2023 (USD MILLION)
TABLE 322. ISRAEL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TREATMENTS, 2024-2030 (USD MILLION)
TABLE 323. ISRAEL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 324. ISRAEL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 325. ISRAEL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 326. ISRAEL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 327. ITALY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 328. ITALY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 329. ITALY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 330. ITALY COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DIAGNOSIS, 2

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • Apollo Health and Lifestyle Limited
  • Augurex Life Sciences Corporation
  • Bayer AG
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Exagen Inc.
  • F. Hoffmann-La Roche Ltd
  • Getinge AB
  • Gilead Sciences, Inc.
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • LeMaitre Vascular, Inc.
  • Merck KGaA
  • Novartis AG
  • PerkinElmer, Inc.
  • Pfizer Inc,
  • QIAGEN GmbH
  • Siemens AG
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech PLC

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 32.21 Billion
Forecasted Market Value ( USD ) by 2030 $ 53.51 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Scleroderma - Pipeline Insight, 2024 - Product Image

Scleroderma - Pipeline Insight, 2024

  • Clinical Trials
  • 180 Pages
  • Global
From
Dystrophic Epidermolysis Bullosa - Pipeline Insight, 2024 - Product Image

Dystrophic Epidermolysis Bullosa - Pipeline Insight, 2024

  • Clinical Trials
  • 75 Pages
  • Global
From
Global Hyaluronic Acid Market Size, Share & Trends Analysis Report by Application (Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux), Region, and Segment Forecasts, 2024-2030 - Product Image

Global Hyaluronic Acid Market Size, Share & Trends Analysis Report by Application (Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux), Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From
India Lymphedema Treatment Market Forecast 2020-2030, and Country Share, Trend, and Growth Opportunity Analysis Coverage: Condition Type, Treatment Type, and End User - Product Image

India Lymphedema Treatment Market Forecast 2020-2030, and Country Share, Trend, and Growth Opportunity Analysis Coverage: Condition Type, Treatment Type, and End User

  • Report
  • 85 Pages
  • India
From
Chondroitin Sulfate Global Market Report 2024 - Product Image

Chondroitin Sulfate Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From

About the Collagen Vascular Disease Drug Market

Collagen Vascular Disease (CVD) Drug is a type of drug used to treat immune disorders. These drugs are used to reduce inflammation and suppress the immune system, which can help reduce the symptoms of CVD. They can also help to reduce the risk of complications from CVD, such as organ damage. CVD drugs are typically prescribed by a doctor and can be taken orally or intravenously. Common CVD drugs include corticosteroids, immunosuppressants, and biologics. Corticosteroids are used to reduce inflammation and suppress the immune system, while immunosuppressants are used to reduce the activity of the immune system. Biologics are used to target specific parts of the immune system and can be used to treat specific conditions. The CVD Drug market is a growing market, with many companies offering a variety of drugs to treat CVD. Some of the major companies in the market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.